home / stock / drmaw / drmaw short
Short Information | Dermata Therapeutics Inc. Warrant (NASDAQ:DRMAW)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 40,639 |
Total Actual Volume | 268,939 |
Short Trends | |
---|---|
Cover Days | 14 |
Short Days | 5 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 2,032 |
Average Short Percentage | 29.66% |
Is there a DRMAW Short Squeeze or Breakout about to happen?
See the DRMAW Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-28-2024 | $0.012899 | $0.014 | $0.014 | $0.012899 | 2,175 | 115 | 5.29% |
06-20-2024 | $0.014 | $0.014 | $0.014 | $0.014 | 100 | 100 | 100% |
05-23-2024 | $0.0159 | $0.0159 | $0.0159 | $0.0159 | 400 | 400 | 100% |
05-17-2024 | $0.0087 | $0.0169 | $0.017 | $0.0086 | 24,989 | 600 | 2.4% |
04-25-2024 | $0.0092 | $0.0095 | $0.0095 | $0.0082 | 3,026 | 311 | 10.28% |
04-10-2024 | $0.0141 | $0.014 | $0.0141 | $0.014 | 27,718 | 2,928 | 10.56% |
03-25-2024 | $0.0114 | $0.011 | $0.0147 | $0.011 | 2,124 | 700 | 32.96% |
03-22-2024 | $0.0114 | $0.0114 | $0.01465 | $0.0114 | 19,669 | 4,000 | 20.34% |
03-12-2024 | $0.01 | $0.01 | $0.0179 | $0.009649 | 27,090 | 13,200 | 48.73% |
03-06-2024 | $0.0107 | $0.0092 | $0.0107 | $0.009 | 15,115 | 100 | 0.66% |
03-04-2024 | $0.017 | $0.0105 | $0.0185 | $0.01 | 44,478 | 1,710 | 3.84% |
03-01-2024 | $0.02 | $0.0179 | $0.02 | $0.0179 | 4,002 | 1,001 | 25.01% |
02-28-2024 | $0.02 | $0.0157 | $0.02 | $0.0157 | 779 | 10 | 1.28% |
02-26-2024 | $0.014301 | $0.0141 | $0.014301 | $0.0141 | 1,804 | 600 | 33.26% |
02-15-2024 | $0.0225 | $0.0125 | $0.0225 | $0.0125 | 2,000 | 1,000 | 50% |
02-08-2024 | $0.0247 | $0.0212 | $0.0247 | $0.0212 | 7,903 | 4,000 | 50.61% |
01-30-2024 | $0.0212 | $0.025 | $0.025 | $0.01 | 53,796 | 2,857 | 5.31% |
01-26-2024 | $0.024 | $0.023899 | $0.024 | $0.023899 | 200 | 100 | 50% |
01-17-2024 | $0.0238 | $0.0172 | $0.0238 | $0.01 | 22,045 | 5,007 | 22.71% |
01-10-2024 | $0.0128 | $0.02074 | $0.025 | $0.0083 | 9,526 | 1,900 | 19.95% |
News, Short Squeeze, Breakout and More Instantly...
Dermata Therapeutics Inc. Warrant Company Name:
DRMAW Stock Symbol:
NASDAQ Market:
Dermata Therapeutics Inc. Warrant Website:
- STAR-1 topline results expected in first quarter of 2025 - - About 30 million acne patients seek treatment in the U.S. each year - - DMT310, if approved, could be the first once-weekly topical product for the treatment of acne - SAN DIEGO, CA / ACCESSWIRE / July 17, 2024 / Derm...
SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreement...
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track - - Dermata continues discussions with potential botulinum toxin partners for DMT410 - - Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis - SAN...